Xeris Pharmaceuticals Stock Price on May 14, 2024
| XERS Stock | USD 3.58 0.03 0.83% |
Below is the normalized historical share price chart for Xeris Pharmaceuticals extending back to June 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Xeris Pharmaceuticals stands at 3.58, as last reported on the 11th of December 2024, with the highest price reaching 3.74 and the lowest price hitting 3.57 during the day.
If you're considering investing in Xeris Stock, it is important to understand the factors that can impact its price. Xeris Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Xeris Pharmaceuticals shows Sharpe Ratio of 0.15, which attests that the company had a 0.15% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Xeris Pharmaceuticals, which you can use to evaluate the volatility of the company. Please utilize Xeris Pharmaceuticals' Market Risk Adjusted Performance of 1.0, downside deviation of 2.73, and Mean Deviation of 1.95 to validate if our risk estimates are consistent with your expectations.
At this time, Xeris Pharmaceuticals' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 144.6 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 203.3 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 0.15 in 2024, whereas Price To Sales Ratio is likely to drop 1.88 in 2024. Xeris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of June 2018 | 200 Day MA 2.5246 | 50 Day MA 3.1484 | Beta 1.285 |
Xeris |
Sharpe Ratio = 0.1488
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XERS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.63 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Xeris Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xeris Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.3354 | Enterprise Value Ebitda (3.36) | Price Sales 2.8724 | Shares Float 142.5 M | Wall Street Target Price 4.7667 |
Related Headline
Elevation Oncology Headline on 14th of May 2024
Elevation Oncology stock gets Overweight rating from Stephen... by investing.com
Elevation Oncology stock gets Overweight rating from Stephens
Xeris Pharmaceuticals Valuation on May 14, 2024
It is possible to determine the worth of Xeris Pharmaceuticals on a given historical date. On May 14, 2024 Xeris was worth 1.91 at the beginning of the trading date compared to the closed value of 1.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Xeris Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Xeris Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xeris Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Xeris Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.81 | 1.97 | 1.77 | 1.89 | 2,133,509 | |
05/14/2024 | 1.91 | 1.98 | 1.84 | 1.90 | 1,693,820 |
| 1.92 | 2.05 | 1.91 | 1.98 | 1,817,347 |
| Backtest Xeris Pharmaceuticals | | | Xeris Pharmaceuticals History | | | Xeris Pharmaceuticals Valuation | Previous | Next |
Xeris Pharmaceuticals Trading Date Momentum on May 14, 2024
| On May 15 2024 Xeris Pharmaceuticals was traded for 1.98 at the closing time. The top price for the day was 2.05 and the lowest listed price was 1.91 . The trading volume for the day was 1.8 M. The trading history from May 15, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 4.21% . The trading price change against the current closing price is 2.63% . |
Xeris Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Xeris Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Xeris Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Xeris financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Xeris Pharmaceuticals Stock history
Xeris Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xeris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xeris Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xeris Pharmaceuticals stock prices may prove useful in developing a viable investing in Xeris Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.7 M | 144.6 M | |
| Net Loss | -85.2 M | -89.5 M |
Xeris Pharmaceuticals Quarterly Net Working Capital |
|
Xeris Pharmaceuticals Stock Technical Analysis
Xeris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Xeris Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Xeris Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Xeris Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Xeris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xeris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xeris Pharmaceuticals stock market strength indicators, traders can identify Xeris Pharmaceuticals entry and exit signals to maximize returns
Xeris Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Xeris Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Xeris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xeris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1382 | |||
| Jensen Alpha | 0.4157 | |||
| Total Risk Alpha | 0.0505 | |||
| Sortino Ratio | 0.1301 | |||
| Treynor Ratio | 0.9949 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Xeris Stock Analysis
When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.